(Q44712852)

English

Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donors (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

author name string

C Kasper

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

H G Sayer

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

L O Mügge

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

K Schilling

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

S Scholl

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

M C Issa

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

K Höffken

7

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

language of work or name

0 references

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

65-69

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704299

21 January 2018

A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704299

21 January 2018

Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704299

21 January 2018

Pharmacokinetics of intravenous mycophenolate mofetil after allogeneic blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704299

21 January 2018

Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704299

21 January 2018

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704299

21 January 2018

Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704299

21 January 2018

Bone-marrow transplantation (first of two parts).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704299

21 January 2018

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704299

21 January 2018

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704299

21 January 2018

The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704299

21 January 2018

Mycophenolate mofetil for the prevention and treatment of graft-versus-host disease following stem cell transplantation: preliminary findings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704299

21 January 2018

Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704299

21 January 2018

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704299

21 January 2018

Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704299

21 January 2018

Increased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704299

21 January 2018

Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704299

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety profile of mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704299

7 January 2021

based on heuristic

inferred from DOI database lookup

New strategies in GVHD prophylaxis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704299

7 January 2021

based on heuristic

inferred from DOI database lookup

New strategies in the treatment of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704299

7 January 2021

based on heuristic

inferred from DOI database lookup

Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704299

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1704299

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

release_3ubhssci3ngullzpcdlnlxmaju

1 reference

https://api.fatcat.wiki/v0/release/3ubhssci3ngullzpcdlnlxmaju

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44712852&oldid=2206863667"